Biomerica, Inc - BMRA Net earnings per share for the last four quarters

Public company logo of Biomerica, Inc (BMRA)

Biomerica, Inc. (BMRA) management is successfully promoting GI tests, securing approvals from US regulators. Analyzing the rolling annual EPS growth chart on GURU.Markets, we note that the -6.50 parameter determines the magnitude of the profit metric. Growth is driven by proprietary nutritional algorithms that provide pricing power, while business reliability is ensured by a conservative staff of top-tier biochemists and experts.

BMRA biomerica.com: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/18/2026

BMRA (Biomerica Inc.): analytical breakdowns and indicator data

- market price and analyst price targets:
Initial company analysis:Biomerica, Inc.
Original product of Biomerica

Biomerica, Inc. (BMRA) pricing power within the IBS diagnostics niche ensures stable cash flows. This indicator measures the trailing twelve-month (TTM) net income per share dynamics, revealing hidden margin compression between quarterly reports. It is critical for investors to track this trend to avoid freezing capital by buying at peaks. By analyzing the historical year-over-year EPS growth (TTM) on GURU.Markets, one can assess the monetization efficiency of the unique InFoods test.

Competitor analysis for Biomerica, Inc.

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Earnings per share for the trailing year|Earnings per share for the last twelve months MDxHealth MDXH|LUCD: Earnings per share for the last 12 months|PRE - Earnings per share for the last twelve months|Earnings per share for the trailing year IMDX (Insight Molecular Diagnostics Inc)|TRIB: Net earnings per share (EPS TTM)|prophaselabs.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HSCS (Heart Test Laboratories Inc.)|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)